PURE Bioscience, Inc. (OTCQB: PURE) develops and commercializes proprietary antimicrobial products, primarily for the food and beverage industry, including food processing and dairy applications. Its technology platform is based on patented, stabilized ionic silver; its products contain silver dihydrogen citrate (SDC), a broad-spectrum, non-toxic antimicrobial agent that formulates well with other compounds. The company positions SDC as offering stronger efficacy, reduced toxicity and mitigation of bacterial resistance compared with incumbent treatment chemistries, though its products are typically more expensive. PURE sells through a distributor network to end users and through technology partnerships. It relies on third-party vendors to manufacture its products and earns small royalty revenue. In fiscal 2026 (ended July 31, 2026) it generated about $2.3 million in net product sales and remained loss-making. It funds operations largely through convertible notes from related parties, part of which are past due, and it carries a stockholders' deficiency. Updated
There are more recognized stocks in today’s edition of the BioHealth Business Daily. We are seeing significant and unusual moves, or implications, in shares of Celgene Corporation (NASDAQ: CELG), DUSA Pharmaceuticals, Inc.…
Today’s wrap of the BioHealth Business Daily includes many less-covered stocks moving on news. We are seeing significant and unusual price changes in shares of Ardea Biosciences, Inc. (NASDAQ: RDEA), Avanir Pharmaceuticals,…
It looks like everyone has figured out that swine flu was more of a media pandemic rather than a disease or viral pandemic. Had this been November as flu season was starting,…
This week there have been many crazy stock gains among the speculative biotech sector, and these were tied directly to the ‘speculative stocks’ that could have any ties in reality, fiction, and…
The Tickerspy index of swine flu and bird flu stocks is up 21% as the market nears its close. The index is being pushed higher by share in Biocryst Pharma (BRCX), which…
PURE Bioscience, Inc. (OTCQB: PURE) develops and commercializes proprietary antimicrobial products, primarily for the food and beverage industry, including food processing and dairy applications.